Cargando…
Single-cell transcriptomics reveals the cell fate transitions of human dopaminergic progenitors derived from hESCs
BACKGROUND: Midbrain dopaminergic (DA) progenitors derived from human pluripotent stem cells are considered to be a promising treatment for Parkinson’s disease (PD). However, the differentiation process produces undesired cell types, which influence the in vivo evaluation of DA cells. In this paper,...
Autores principales: | Liang, Lingmin, Tian, Yao, Feng, Lin, Wang, Chaoqun, Feng, Guihai, Stacey, Glyn Nigel, Shyh-Chang, Ng, Wu, Jun, Hu, Baoyang, Li, Wei, Hao, Jie, Wang, Liu, Wang, Yukai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375405/ https://www.ncbi.nlm.nih.gov/pubmed/35964138 http://dx.doi.org/10.1186/s13287-022-03104-7 |
Ejemplares similares
-
Neuronal cell‐based medicines from pluripotent stem cells: Development, production, and preclinical assessment
por: Sun, Yun, et al.
Publicado: (2021) -
Infusion of hESC derived Immunity‐and‐matrix regulatory cells improves cognitive ability in early‐stage AD mice
por: Liu, Jing, et al.
Publicado: (2021) -
Single-Cell Transcriptome Profiling of Mouse and hESC-Derived Pancreatic Progenitors
por: Krentz, Nicole A.J., et al.
Publicado: (2018) -
hESC-derived immune suppressive dendritic cells induce immune tolerance of parental hESC-derived allografts
por: Todorova, Dilyana, et al.
Publicado: (2020) -
Genome editing HLA alleles for a pilot immunocompatible hESC line in a Chinese hESC bank for cell therapies
por: Ji, Tian‐Tian, et al.
Publicado: (2023)